Диссертация (1140920), страница 18
Текст из файла (страница 18)
International journal of cancer 2017, 141(11):2228-2242.Hoffman RM, Meisner AL, Arap W, Barry M, Shah SK, Zeliadt SB, WigginsCL: Trends in United States Prostate Cancer Incidence Rates by Age andStage, 1995-2012. Cancer epidemiology, biomarkers & prevention : apublication of the American Association for Cancer Research, cosponsoredby the American Society of Preventive Oncology 2016, 25(2):259-263.Wong MC, Goggins WB, Wang HH, Fung FD, Leung C, Wong SY, Ng CF,Sung JJ: Global Incidence and Mortality for Prostate Cancer: Analysis ofTemporal Patterns and Trends in 36 Countries. European urology 2016,70(5):862-874.Sandhu GS, Andriole GL: Overdiagnosis of prostate cancer. Journal of theNational Cancer Institute Monographs 2012, 2012(45):146-151.Stamatiou K, Alevizos A, Agapitos E, Sofras F: Incidence of impalpablecarcinoma of the prostate and of non-malignant and precarcinomatouslesions in Greek male population: an autopsy study.
The Prostate 2006,66(12):1319-1328.Dudarev AA, Chupakhin VS, Odland JO: Cancer incidence and mortalityin Chukotka, 1997-2010. International journal of circumpolar health 2013,72:20470.Давыдов МИ, Аксель ЕМ: Статистика злокачественныхновообразований в России и странах СНГ в 2012 г. In.: Ассоциациядиректоров центров и институтов онкологии, радиологии ирентгенологии государств-участников Содружества НезависимыхГосударств. Российский онкологический научный центр имени Н.Н.Блохина; Москва, 2014 г.Shao YH, Demissie K, Shih W, Mehta AR, Stein MN, Roberts CB, DipaolaRS, Lu-Yao GL: Contemporary risk profile of prostate cancer in theUnited States.
Journal of the National Cancer Institute 2009, 101(18):12801283.Adams J: The case of scirrhous of the prostate gland with correspondingaffliction of the lymphatic glands in the lumbar region and in the pelvis.Lancet 1853:393.Hsing AW, Yeboah E, Biritwum R, Tettey Y, De Marzo AM, Adjei A, NettoGJ, Yu K, Li Y, Chokkalingam AP et al: High prevalence of screen detected10912.13.14.15.16.17.18.19.20.21.22.23.24.prostate cancer in West Africans: implications for racial disparity ofprostate cancer. The Journal of urology 2014, 192(3):730-735.De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D,Trama A, Visser O, Brenner H, Ardanaz E et al: Cancer survival in Europe1999-2007 by country and age: results of EUROCARE--5-a populationbased study.
The Lancet Oncology 2014, 15(1):23-34.Loeb S: Guideline of guidelines: prostate cancer screening. BJUinternational 2014, 114(3):323-325.Wang MC, Valenzuela LA, Murphy GP: Purification of a human prostatespecific antigen. Urology 1979, 17:159-163.Papsidero LD, Wang MC, Valenzuela LA: A prostate antigen in sera ofprostatic cancer patients. Cancer Research 1980, 40:2428-2432.Алексеев БЯ, Калпинский АС: Роль простатспецифического антигенав диагностике рака предстательной железы. Российскийонкологический журнал 2007, 6:43-46.Stattin P, Carlsson S, Holmstrom B, Vickers A, Hugosson J, Lilja H, JonssonH: Prostate cancer mortality in areas with high and low prostate cancerincidence. Journal of the National Cancer Institute 2014, 106(3):dju007.Kitagawa Y, Ueno S, Izumi K, Kadono Y, Konaka H, Mizokami A, NamikiM: Cumulative probability of prostate cancer detection in biopsyaccording to free/total PSA ratio in men with total PSA levels of 2.1-10.0ng/ml at population screening.
Journal of cancer research and clinicaloncology 2014, 140(1):53-59.Verma A, St Onge J, Dhillon K, Chorneyko A: PSA density improvesprediction of prostate cancer. The Canadian journal of urology 2014,21(3):7312-7321.Murray NP, Reyes E, Orellana N, Fuentealba C, Duenas R: A comparativeperformance analysis of total PSA, percentage free PSA, PSA velocity,and PSA density versus the detection of primary circulating prostate cellsin predicting initial prostate biopsy findings in Chilean men.
BioMedresearch international 2014, 2014:676572.Prostate cancer detection. In.: National comprehensive cancer network;2014.Hodge KK, McNeal JE, Terris MK, Stamey TA: Random systematic versusdirected ultrasound guided transrectal core biopsies of the prostate. TheJournal of urology 1989, 142(1):71-74; discussion 74-75.Djavan B, Zlotta AR, Ekane S, Remzi M, Kramer G, Roumeguere T, EtemadM, Wolfram R, Schulman CC, Marberger M: Is one set of sextant biopsiesenough to rule out prostate Cancer? Influence of transition and totalprostate volumes on prostate cancer yield.
European urology 2000,38(2):218-224.Ploussard G, Nicolaiew N, Marchand C, Terry S, Vacherot F, Vordos D,Allory Y, Abbou CC, Salomon L, de la Taille A: Prospective evaluation of11025.26.27.28.29.30.31.32.33.34.35.an extended 21-core biopsy scheme as initial prostate cancer diagnosticstrategy. European urology 2014, 65(1):154-161.Nelson AW, Harvey RC, Parker RA, Kastner C, Doble A, GnanapragasamVJ: Repeat prostate biopsy strategies after initial negative biopsy: metaregression comparing cancer detection of transperineal, transrectalsaturation and MRI guided biopsy.
PloS one 2013, 8(2):e57480.Коссов ФА, Камолов БШ, Абдуллин ИИ, Баранова ЕО, Шориков МА,Панов ВО, Тюрин ИЕ, Матвеев ВБ, Григорьев НА, Долгушин БИ:Применение мрт/узи fusion-биопсии в диагностике клиническизначимого рака предстательной железы. Онкоурология 2017, 13(3):6170.Абдуллин ИИ, Коссов ФА, Камолов БШ, Орлов ОС, Баранова ЕО,Григорьев НА, Панов ВО, Тюрин ИЕ, Долгушин БИ: Современныевозможности мрт/узи fusion-биопсии в диагностике ракапредстательной железы Вопросы урологии и андрологии 2017, 5(2):3744.Tsivian M, Abern MR, Qi P, Polascik TJ: Short-term functional outcomesand complications associated with transperineal template prostatemapping biopsy.
Urology 2013, 82(1):166-170.Grummet JP, Weerakoon M, Huang S, Lawrentschuk N, Frydenberg M,Moon DA, O'Reilly M, Murphy D: Sepsis and 'superbugs': should wefavour the transperineal over the transrectal approach for prostatebiopsy? BJU international 2014, 114(3):384-388.Panach-Navarrete J, Garcia-Morata F, Hernandez-Medina JA, MartinezJabaloyas JM: When to biopsy seminal vesicles.
Actas urologicas espanolas2015, 39(4):203-209.Linzer DG, Stock RG, Stone NN, Ratnow R, Ianuzzi C, Unger P: Seminalvesicle biopsy: accuracy and implications for staging of prostate cancer.Urology 1996, 48(5):757-761.Montoya-Chinchilla R, Rosino-Sanchez A, Fernandez-Aparicio T, CanoGarcia MC, Hidalgo-Agullo G, Reina-Alcaina L, Carrillo-George C,Izquierdo-Morejon E, Minana-Lopez B: Seminal vesicle biopsies: an usefulstaging procedure-exposure of seminal vesicle biopsies protocol andreview of the literature.
International urology and nephrology 2014,46(1):297-302.Keetch DW, Catalona WJ, Smith DS: Serial prostatic biopsies in men withpersistently elevated serum prostate specific antigen values. The Journalof urology 1994, 151(6):1571-1574.Аляев ЮГ, Синицин ВЕ, Григорьев НА (eds.): Магнитно-резонанснаятомография в урологии: Практическая медицина; 2005.Аляев ЮГ, Винаров АЗ, Григорьев НА, Безруков ЕА: Динамическаямагнитно-резонансная простатовезикулография в диагностикелокализованных стадий рака простаты.
Сибирский онкологическийжурнал 2002, 3-4:24.11136.37.38.39.40.41.42.43.44.45.46.Pasoglou V, Larbi A, Collette L, Annet L, Jamar F, Machiels JP, Michoux N,Vande Berg BC, Tombal B, Lecouvet FE: One-step TNM staging of highrisk prostate cancer using magnetic resonance imaging (MRI): toward anupfront simplified "all-in-one" imaging approach? The Prostate 2014,74(5):469-477.Mattei A, Danuser H: Contemporary imaging analyses of pelvic lymphnodes in the prostate cancer patient. Current opinion in urology 2011,21(3):211-218.Perrotti M, Kaufman RP, Jr., Jennings TA, Thaler HT, Soloway SM, RifkinMD, Fisher HA: Endo-rectal coil magnetic resonance imaging in clinicallylocalized prostate cancer: is it accurate? The Journal of urology 1996,156(1):106-109.Jager GJ, Barentsz JO, Oosterhof GO, Witjes JA, Ruijs SJ: Pelvicadenopathy in prostatic and urinary bladder carcinoma: MR imagingwith a three-dimensional TI-weighted magnetization-prepared-rapidgradient-echo sequence.
AJR American journal of roentgenology 1996,167(6):1503-1507.Saokar A, Islam T, Jantsch M, Saksena MA, Hahn PF, Harisinghani MG:Detection of lymph nodes in pelvic malignancies with ComputedTomography and Magnetic Resonance Imaging. Clinical imaging 2010,34(5):361-366.Sankineni S, Brown AM, Fascelli M, Law YM, Pinto PA, Choyke PL,Turkbey B: Lymph node staging in prostate cancer. Current urologyreports 2015, 16(5):30.Raskolnikov D, George AK, Rais-Bahrami S, Turkbey B, Siddiqui MM,Shakir NA, Okoro C, Rothwax JT, Walton-Diaz A, Sankineni S et al: TheRole of Magnetic Resonance Image Guided Prostate Biopsy in StratifyingMen for Risk of Extracapsular Extension at Radical Prostatectomy. TheJournal of urology 2015.Аляев ЮГ, Терновой СК, Синицин ВЕ, Григорьев НА, Безруков ЕА,Морозов СП, Шестипёров ПА: Диагностические возможностиэндоректальной магнитно-резонансной томографии в стадированиирака предстательной железы.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
